February 10, 2020
Japan’s Ministry of Health, Labour and Welfare (MHLW) published Notification No. 0106-1 (Yakuseiki-shin-hatu #0106-1), which requires manufacturers to evaluate the biocompatibility of medical devices in accordance with JIS T 0993-1:2020. The JIS T 0993-1 standard is a translated Japanese version of ISO 10993-1 and is updated periodically to bring it in line with revisions to the parent document. There are no differences in the technical requirements between the two standards.
History of JIST T 0993-1 revisions and related guidance
The original edition of JIST T 0993-1 was released in 2005 based on ISO 10993-1:2003; it was revised in 2012 to align with ISO 10993-1:2007. JIS T 0993-1:2020 was issued on January 1, 2020 to align with ISO 10993-1:2018.
The MHLW previously released two guidance documents stipulating the biocompatibility data required for Pre-market Approval (PMA) and Pre-market Certification (PMC) under JIS T0993-1: Iyaku-shin-hatsu #0213001 and Yakushokuki-hatsu #0301-20.
Impact on medical device manufacturers
Manufacturers of medical devices who are applying for either PMA or PMC may submit biocompatibility results based on JIS T 0993-1:2020 (equivalent to ISO 10993-1:2018). However, it should be noted that both PMA and PMC require testing to each endpoint listed in JIS T 0993-1:2020 Annex A.1. The testing must be conducted in compliance with Good Laboratory Practice (GLP), and compliance with ISO 17025 will not suffice.
More information about Japanese medical device regulations:
- Japan PMDA medical device registration and approval consulting
- Foreign manufacturer registration in Japan
- Japan MHLW Ordinance 169 quality system compliance
- Regulatory process chart: Japanese medical device registration
Request information from our specialists
Thanks for your interest in our products and services. Let's collect some information so we can connect you with the right person.